stockrowHealthEquity, Inc.
HQY Healthcare Health Information Services
HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025.
- Revenue
- +7.64%
- EPS
- +14.5%
- Free cash flow
- −3.44%
- Total debt
- −7.53%
Quarter to July 2026, against a year earlier
Follow HQY
Alert me
HealthEquity, Inc. (HQY) EBITDA
HealthEquity, Inc.'s EBITDA for fiscal 2026 was $478.2M, up 46.3% from $326.9M in fiscal 2025. Over the twelve months to 31 July 2026 it was $510.0M. Over the past ten years it has ranged from $22.8M (fiscal 2015) to $478.2M (fiscal 2026) — the current reading is the highest in ten years. EBITDA has risen for 4 consecutive fiscal years. HealthEquity, Inc. ranks 3rd of 43 Health Information Services companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2026 | $478.2M | 46.30% |
| FY2025 | $326.9M | 19.45% |
| FY2024 | $273.6M | 57.69% |
| FY2023 | $173.5M | 47.80% |
| FY2022 | $117.4M | (24.27%) |
| FY2021 | $155.0M | 14.77% |
| FY2020 | $135.1M | 40.82% |
| FY2019 | $95.9M | 36.30% |
| FY2018 | $70.4M | 29.36% |
| FY2017 | $54.4M | 56.46% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jul 2026 | $141.0M | (0.21%) |
| Apr 2026 | $141.2M | 28.39% |
| Jan 2026 | $110.0M | (6.57%) |
| Oct 2025 | $117.7M | (8.25%) |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $690.0M |
| HQY HealthEquity, Inc. | $510.0M |
| WAY Waystar Holding Corp. compare | $444.3M |
| DOCS Doximity, Inc. compare | $218.1M |
| HNGE Hinge Health Inc. compare | $161.2M |
| PRVA Privia Health Group, Inc. compare | $63.8M |
| HTFL Heartflow, Inc. compare | −$72.7M |
| SDGR Schrodinger, Inc. compare | −$127.8M |
| TEM Tempus AI, Inc. compare | −$166.8M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on HQY
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement